Atlas Trials

Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

Clinical trial NCT02493322 · WITHDRAWN

Trial details

NCT number
NCT02493322
Sponsor
EMS
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Essential Arterial Hypertension
Primary completion
2025-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.